$CALM

Cal-Maine Falls To Loss In Q4, Shares Down

Cal-Maine Foods (CALM) reported a Q4 2026 net loss of $35.88 million versus a $342.48 million profit a year earlier. Net loss per share was $0.76 versus EPS of $7.01. Revenue fell 49.9% to $552.58 million from $1.10 billion. Shares were down about 4.69% premarket to $83.16 on Nasdaq.

Original reporting
Published Jul 22, 2026, 1:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 22, 2026, 1:46 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Cal-Maine Falls To Loss In Q4, Shares Down — source image
Decision brief

The 30-second read

$CALMBearishMed
01

Why it matters

A large year-over-year revenue contraction and a major EPS swing to a loss are likely to trigger estimate cuts and multiple compression until management provides stabilization signals.

02

Market read

Traders can use the reported loss, revenue decline, and pre-market weakness to update near-term earnings expectations for CALM.

03

What to watch

No guidance, balance-sheet detail, or management commentary is included, limiting the ability to judge whether margins are structurally impaired versus cyclical.

Relevance 8/10Novelty 7/10Timing: pre-market reaction to Q4 2026 results

Background

Cal-Maine Foods is a poultry company; the article reports its Q4 2026 results versus the prior year.

Company-level read

Ticker impact

$CALMBearishHigh confidence
Context

Cal-Maine Foods reported a Q4 2026 slip to loss, with revenue down 49.9% to $552.58M and EPS swinging to -$0.76.

Expected impact

Bearish bias for the next few sessions as traders reprice earnings power and margin expectations.

Evidence & confidence

The article provides concrete Q4 loss, EPS swing, and a large revenue decline, which are direct drivers of earnings revisions and valuation.

Market effects

Weak poultry earnings can reinforce caution on poultry producers and feed-cost or demand assumptions, though no peer-specific read-across is provided here.

No regional-specific impacts mentioned.

No global macro or international demand details provided.

Counterpoint

The article does not break out one-time items or cost drivers; if the decline is temporary (e.g., timing of volumes or pricing), the selloff could overstate longer-term earnings power.

Key entities

  • Cal-Maine Foods, Inc.

    Reported Q4 2026 loss with revenue down 49.9% and EPS of -$0.76 versus prior-year profit/EPS of $7.01.

Related articles

$CALMMedAI 8/10

Why Cal-Maine Foods Stock Just Cracked

Cal-Maine Foods (NASDAQ: CALM) shares fell about 3.7% by 9:45 a.m. ET after reporting Q4 results. Analysts expected EPS of $0.11 on $657M sales, but the company reported a loss of $0.76 per share on $552.6M sales. CEO Sherman Miller cited industry oversupply and low wholesale egg prices. 2026 revenue fell 32% and profit fell 73%.

$CALMMedAI 8/10

Cal-Maine Foods Stock Slips on Surprise Q4 Loss

Cal-Maine Foods (NASDAQ:CALM) shares fell after the company reported a fiscal Q4 loss of 76 cents per share, versus analysts expecting a profit of 11 cents. The firm cited historically low inflation-adjusted egg prices. Revenue dropped 49.9% year over year to $552.6 million. Stock was down 2.7% near $84.96.

$SMCIMed

Stocks making the biggest moves premarket: Super Micro Computer, GE Vernova, Rocket Lab and more

Premarket movers included Super Micro Computer, up about 17% after preliminary Q4 results showed stronger profitability than expected, with revenue near low guidance. GE Vernova fell over 7% despite a revenue beat and raised full-year guidance. Rocket Lab rose about 4% on a $266 million U.S. Air Force contract. Pegasystems dropped over 14% after Q2 missed estimates; others moved on earnings or nuclear/AI news.

$CALMMed

Maine (NASDAQ:CALM) Misses Q2 CY2026 Sales Expectations

Cal-Maine Foods (NASDAQ: CALM) reported Q2 CY2026 revenue of $552.6 million, down 49.9% year over year, missing market expectations. The company posted a GAAP loss of $0.76 per share, better than analysts’ consensus. Management cited strategy to improve product mix and pricing. The stock fell 2.2% to $85.37 after results.